Avalyn Pharma Inc. Common Stock (AVLN)

Avalyn Pharma Inc. Common Stock (AVLN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -4.4%, 1 week +10.1%.

Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company specialized in developing inhaled formulations of established antifibrotic therapies to treat rare respiratory diseases. The company's primary focus is on Progressive Pulmonary Fibrosis (PPF) and Idiopathic Pulmonary Fibrosis (IPF).

Groups AVLN belongs to

• Recent IPOs

AVLN financial model: income statement, cash flow and balance sheet